Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial
Clinical Gastroenterology and Hepatology · 2026-08 · 24 (8) · 2286-2296
DOI: 10.1016/j.cgh.2026.01.014 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-08. Verfasst von Nicolaas Koen Vermeijden und 18 weiteren Autor:innen. Beteiligte Einrichtung: Emma's Children Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Gastroenterology, Hepatology, and Nutrition, Amsterdam, The Netherlands; …. Hauptthemen laut MEDLINE: Plant Oils, Irritable Bowel Syndrome, Abdominal Pain, Parasympatholytics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: St. Antonius Ziekenhuis.
Abstract (Originalsprache)
BACKGROUND & AIMS: Effective pharmacologic treatment for pediatric irritable bowel syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP-NOS) is lacking. This study evaluated the efficacy and safety of peppermint oil, an antispasmodic agent, and peppermint sweets in children with IBS or FAP-NOS. METHODS: This randomized controlled trial was conducted across 13 Dutch hospitals. Participants (aged 8-18 years) with IBS or FAP-NOS were randomized (1:1:1) to double-blind peppermint oil capsules (containing 182 mg of peppermint oil), open-label peppermint sweets (9.2 mg peppermint oil), or double-blind placebo (2.0 mg peppermint oil to enhance blinding) twice daily (8-11 years) or 3 times daily (12-18 years), with dose escalation if needed. The intervention lasted 8 weeks with a 4-week follow-up. The primary endpoint was treatment success, defined as a ≥30% reduction of abdominal pain intensity after 8 weeks. The key secondary endpoint was adequate relief of symptoms. RESULTS: In 228 children (8-11 years: n = 92; 12-18 years: n = 135; 75-78 per group), treatment success was comparable between patients receiving peppermint oil (n = 30; 44.0%) and placebo (n = 28; 37.3%) (odds ratio [OR], 1.33; 97.5% confidence interval [CI], 0.58-3.09; P = .44), and between placebo and peppermint sweets (n = 30; 38.7%) (OR, 1.05; 97.5% CI, 0.45-2.44; P = .91). Adequate relief was comparable between treatment groups: peppermint oil (n = 40; 53.3%) vs placebo (n = 37; 49.3%) (OR, 1.15; 97.5% CI, 0.54-2.47; P = .68), and placebo vs peppermint sweets (n = 35; 44.9%) (OR, 0.81; 97.5% CI, 0.39-1.71; P = .53). Adverse events were mild and infrequent. CONCLUSIONS: Neither peppermint oil nor peppermint sweets were superior to placebo in treating pediatric IBS and FAP-NOS. These findings suggest prioritizing proven gut-brain axis-targeted interventions for this population. CLINICALTRIALS: gov, Number: NCT05799053.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emma's Children Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Gastroenterology, Hepatology, and Nutrition, Amsterdam, The Netherlands; Amsterdam Reproduction and Development Research Institute, Amsterdam U…
- Department of Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
- Department of Pediatrics, Maasstad Hospital, Rotterdam, The Netherlands.
- Department of Pediatrics, Medisch Spectrum Twente, Enschede, The Netherlands.
- Department of Pediatrics, Máxima Medisch Centrum, Veldhoven, The Netherlands.
- Department of Pediatrics, Amphia Hospital, Breda, The Netherlands.
Förderung
- St. Antonius Ziekenhuis
Zitieren
APA
Vermeijden, N. K., van der Feen, C., Groeneweg, M., Hummel, T., Zagers, D., Bertrams-Maartens, I., van Wering, H., Hurkmans, P., Stapelbroek, J., Sauvé, I., Wessels, M., Teklenburg-Roord, S., Pruijsen-Nienhuis, J. M., Theuns-Valks, S. D. M., Plomp, T. C., Bunkers, C., Keszthelyi, D., Benninga, M. A., & Vlieger, A. M. (2026). Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial. Clinical Gastroenterology and Hepatology, 24(8), 2286-2296. https://doi.org/10.1016/j.cgh.2026.01.014
Vancouver
Vermeijden NK, van der Feen C, Groeneweg M, Hummel T, Zagers D, Bertrams-Maartens I, et al. Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial. Clinical Gastroenterology and Hepatology. 2026;24(8):2286-2296. doi:10.1016/j.cgh.2026.01.014
BibTeX
@article{Vermeijden2026,
author = {Vermeijden, Nicolaas Koen and van der Feen, Cathelijne and Groeneweg, Michael and Hummel, Thalia and Zagers, Deborah and Bertrams-Maartens, Imke and van Wering, Herbert and Hurkmans, Pamela and Stapelbroek, Janneke and Sauvé, Inge and Wessels, Margreet and Teklenburg-Roord, Sarah and Pruijsen-Nienhuis, Jessica M and Theuns-Valks, Sabine D M and Plomp, Thirza C and Bunkers, Carin and Keszthelyi, Daniel and Benninga, Marc A and Vlieger, Arine M},
title = {Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {8},
pages = {2286--2296},
doi = {10.1016/j.cgh.2026.01.014}
}
EUVIMED